IMC-2017 is under clinical development by ImmuneCyte and currently in Phase I for Spinal Cord Disorders. According to GlobalData, Phase I drugs for Spinal Cord Disorders have an 86% phase transition ...
A headache, difficulty thinking, personality changes, and movement disorders such as tremors or ataxia (lack of coordination ... In the spinal cord, the cysts can cause spinal cord compression and ...
Neurological disorders are disorders that affect the central nervous system or the peripheral nervous systems and can impair the brain, spinal cord, peripheral nerve or neuromuscular function.
Migraine is one of the most severe and debilitating brain disorders ... central projection of the trigeminovascular system, the trigeminal nucleus caudalis and the C1 and C2 regions of the spinal ...
Introduction Neurogenic bladder is one of the most common complications following spinal cord injury (SCI). In China, acupuncture therapy is a common ... Methods and analysis Eight databases will be ...
Scientists traced connectivity between neurons to identify how the brain communicates with the spinal cord to control motor function. Signals relayed to motor neurons from the brain enable muscle ...